#Clinical Trials

🏢Release 📈 Stocks

Mozart Therapeutics Reports Positive Phase 1 Data for MTX-101 in Type 1 Diabetes

October 5, 2026 (19 days ago)

Mozart Therapeutics advances its clinical pipeline with positive Phase 1 and preclinical data for MTX-101, showing therapeutic potential in treating Stage 3…

Mozart Therapeutics

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

AbbVie and Genmab Report Positive Phase 3 Results for Epcoritamab in DLBCL

October 5, 2026 (19 days ago)

AbbVie and Genmab shares gain as the EPCORE DLBCL-2 trial demonstrates superior progression-free survival for frontline lymphoma patients using their bispecific antibody…

ABBV GMAB

🌍 GLOBAL Read More →

🏢Release 📈 Stocks

Resonant Acquires Labfish to Expand European Clinical Trial Capabilities

October 5, 2026 (19 days ago)

Resonant acquires Labfish to enhance its European clinical trial infrastructure, adding specialized calibration and global partner depot capabilities to its service portfolio.

Labfish

🌍 GLOBAL Read More →

🏢Release 📈 Stocks

Provectus Biopharmaceuticals Reports 95.5% Response Rate in Oral Cancer Trial

October 5, 2026 (19 days ago)

Provectus Biopharmaceuticals shares rally as Phase 2 trial data for PRV111 shows a 95.5% pathologic complete response rate in early-stage oral cancer…

PVCT

🌍 AMERICAS Read More →

🏢Release 📈 Stocks — 📊 Neutral

saRNA Therapy Delivers 5.3-Fold Utrophin Increase in Human Muscle Trials

October 3, 2026 (21 days ago)

Clinical trial results show systemically delivered saRNA safely boosts utrophin expression by up to 5.3-fold in human skeletal muscle, marking a breakthrough…

🌍 ASIA Read More →

🏢Release 📈 Stocks — 📊 Neutral

New Durable Biologic Implant Targets 2027 Clinical Entry for Year-Long Efficacy

October 2, 2026 (22 days ago)

A new durable implant set for 2027 clinical trials promises to extend the efficacy of biologic treatments to a full year, potentially…

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Astellas Pharma Reports Positive Real-World Sleep Data for VEOZAH

October 2, 2026 (22 days ago)

Astellas Pharma's VEOZAH shows significant improvements in sleep quality and menopause symptoms in new real-world study data, bolstering the drug's commercial outlook.

ALPMY

🌍 GLOBAL Read More →

🏢Release 📈 Stocks

ZYUS Life Sciences Reports Positive Phase 2a Results for Trichomylin

October 1, 2026 (23 days ago)

ZYUS Life Sciences shares gain momentum as Phase 2a UTOPIA-1 trial data confirms Trichomylin efficacy and safety for cancer pain management.

ZYUS

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Tenex Health Reports Positive 6-Month Clinical Results for TenJet Device

October 1, 2026 (23 days ago)

Tenex Health's TenJet device shows strong clinical performance in a six-month study, potentially accelerating commercial adoption for the minimally invasive treatment of…

TENX

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Lutris Pharma Reports 71.8% Success Rate in Phase 2 LUT014 Gel Trial

October 1, 2026 (23 days ago)

Lutris Pharma shares gain momentum after reporting that its LUT014 0.1% gel significantly outperformed placebo in Phase 2 trials, achieving a 71.8%…

Lutris Pharma

🌍 AMERICAS Read More →

🏢Release 📈 Stocks — 📊 Neutral

Gore Enrolls First Patient in IBE Plus Pivotal Study for Vascular Treatment

October 1, 2026 (23 days ago)

W. L. Gore & Associates initiates the IBE Plus Pivotal Study, marking a key milestone in the clinical evaluation of its latest…

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Qidii Shares Rally as Qi601 Clinical Study Validates Microplastic Capture

October 1, 2026 (24 days ago)

Qidii, Inc. reports successful human proof-of-concept for its Qi601 technology, confirming the device's efficacy in capturing microplastics in a peer-reviewed study.

QIDI

🌍 AMERICAS Read More →